Table 1 Clinical data
From: Assessment of Surfactant Protein A (SP-A) dependent agglutination
Clinical characteristics | Cystic fibrosis (n = 10) | Chronic bronchitis (n = 10) | Controls (n = 11) |
|---|---|---|---|
Age | 14 ± 3 (10) | 4 ± 4 (10) | 12 ± 8 (11) |
Gender (% female) | 6 (60) | 8 (80) | 3 (27) |
BMI %, (n) (overweight/normal/underweight) | 40/30/30 (4/3/3) | 0/100/0 (0/10/0) | 0/100/0 (0/11/0) |
Fev 1 (% pred.) | 97 ± 31 (10) | 109 ± 15 (3) | 118 (1) |
SP-A level in serum (ng/ml) | 26 ± 10 (10) | 28 ± 24 (2) | 17 ± 4 (10) |
SP-A level in BAL (ng/ml) | 4993 ± 2984 (10) | 4094 ± 1363 (3) | 6645 ± 5354 (11) |
Neutrophils in BAL (%) | 42 ± 29 (10) | 9 ± 9 (5) | 2.5 ± 4 (4) |